Filing Details

Accession Number:
0001179110-14-001113
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-01-16 18:00:17
Reporting Period:
2014-01-14
Filing Date:
2014-01-16
Accepted Time:
2014-01-16 18:00:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1113481 Medicines Co MDCO Pharmaceutical Preparations (2834) 043324394
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1427141 Bernard William O'connor 8 Sylvan Way
Parsippany NJ 07054
Sr Vp & Chief Acct. Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-01-14 1,094 $7.31 26,152 No 4 M Direct
Common Stock Acquisiton 2014-01-14 2,083 $17.45 28,235 No 4 M Direct
Common Stock Disposition 2014-01-14 3,177 $38.81 25,058 No 4 S Direct
Common Stock Acquisiton 2014-01-15 1,250 $22.04 26,308 No 4 M Direct
Common Stock Disposition 2014-01-15 1,250 $40.00 25,058 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right-to-buy) Disposition 2014-01-14 1,094 $0.00 1,094 $7.31
Common Stock Stock Option (right-to-buy) Disposition 2014-01-14 2,083 $0.00 2,083 $17.45
Common Stock Stock Option (right-to-buy) Disposition 2014-01-15 1,250 $0.00 1,250 $22.04
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
729 2020-02-19 No 4 M Direct
9,722 2021-02-18 No 4 M Direct
10,833 2022-02-24 No 4 M Direct
Footnotes
  1. The common stock sales were effected pursuant to a Rule 10b5-1 program adopted by the reporting person on March 15, 2013.
  2. Represents the weighted average sales price of the shares sold ranging from a low of $38.70 to a high of $39.04 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  3. This option vests in forty-eight equal monthly installments beginning March 19, 2010.
  4. This option vests in forty-eight equal monthly installments beginning March 18, 2011.
  5. This option vests in forty-eight equal monthly installments beginning March 24, 2012.
  6. Not Applicable.